Skip to Main Content

Paper Details

The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models.
Clin Cancer Res
53
2021
B7-H3, CD276 gene, CDX, CDX models, Ewing sarcoma, MCR, PBD, PDX, Patients, Pediatric Cancer, RNA, Solid Tumor, Wilms tumors, cell line-derived xenograft, m276, mouse, neuroblastoma, osteosarcoma, patient, patients, pediatric PDX microarrays, pediatric cancers, pediatric solid malignancies, pediatric solid malignancy, pediatric solid tumor PDX models, rhabdomyosarcoma, solid tumor
Author NameAffiliation
Nathan M KendserskyDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Nathan M KendserskyPerelman School of Medicine, University of Pennsylvania
Edward A KolbA.I. duPont Hospital for Children
Malcolm A Smith
Malcolm A Smith
Yael P MosseDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Daniel MartinezChildren's Hospital of Philadelphia
Daniel MartinezChildren's Hospital of Philadelphia
Jennifer PogorilerPerelman School of Medicine, University of Pennsylvania
Jennifer PogorilerChildren's Hospital of Philadelphia
Jennifer PogorilerPerelman School of Medicine, University of Pennsylvania
Jennifer PogorilerChildren's Hospital of Philadelphia
Kateryna KrytskaDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Khushbu PatelDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
Khushbu PatelChildren's Hospital of Philadelphia
Richard GorlickChildren's Cancer Hospital, The University of Texas MD Anderson Cancer Center
Richard GorlickChildren's Cancer Hospital, The University of Texas MD Anderson Cancer Center
Raushan T KurmashevaGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio
Peter J HoughtonGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio
John M MarisDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
John M MarisPerelman School of Medicine, University of Pennsylvania
John M MarisDivision of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia
John M MarisPerelman School of Medicine, University of Pennsylvania
  • 1 - 23

Datasets